Craig W. Wiesenhutter

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Cevimeline for the Treatment of Xerostomia in Patients With Sjögren Syndrome

Rose Fife, Walter F. Chase, Robin K. Dore et al. · Archives of Internal Medicine · 2002 · 194 citations · Full text

Dentistry, Oral Medicine, Allergy +16

Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: A six‐month, double‐blind, randomized, dose‐ranging study

Daniel E. Fürst, Kenneth G. Saag, Max Fleischmann et al. · Arthritis & Rheumatism · 2002 · 116 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study

Philip J. Mease, Nathan Wei, Edward J. Fudman et al. · The Journal of Rheumatology · 2009 · 112 citations · Full text

Medicine, Clinical Sciences, Immunology +17

A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.

John Bradley, Alexei Dmitrienko, Alan Kivitz et al. · PubMed · 2005 · 109 citations

Medicine, Pharmacology, Pharmacotherapy +16